Comparison between anteroposterior and oblique Scotty dog approach during S1 transforaminal epidural steroid injection: A randomized controlled trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Ryung A. | - |
dc.contributor.author | Sim, Woo Seog | - |
dc.contributor.author | Choi, Ji Won | - |
dc.contributor.author | Kang, Sehee | - |
dc.contributor.author | Lee, Seungwon | - |
dc.contributor.author | Jee, Hyeon Sook | - |
dc.contributor.author | Oh, Eun Jung | - |
dc.contributor.author | Kim, Yunghun | - |
dc.contributor.author | Ko, Justin Sangwook | - |
dc.date.accessioned | 2024-06-18T08:00:24Z | - |
dc.date.available | 2024-06-18T08:00:24Z | - |
dc.date.issued | 2020-10 | - |
dc.identifier.issn | 0025-7974 | - |
dc.identifier.issn | 1536-5964 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74294 | - |
dc.description.abstract | Background:Traditionally, S1 transforaminal epidural steroid injection (TFESI) has been performed using an anteroposterior (AP) fluoroscopic view. In 2007, the oblique Scotty dog (OS) approach was introduced as an alternative technique. We compared passage time of the needle into S1 foramen (Tf) between the anteroposterior (AP) and oblique Scotty dog (OS) approach during S1 TFESI.Methods:In this prospective randomized controlled trial, seventy patients scheduled S1 TFESI were randomly allocated into AP or OS groups. In the AP group, a slight cephalad-caudad tilt was used. In the OS group, the C-arm was rotated ipsilateral oblique degrees to view the S1 Scotty dog. Both groups received injection of steroid mixed with local anesthetics. We measured the passage time of the needle into S1 foramen (Tf), primary outcome, and total procedure time (Tt) between the groups. We also recorded presence of intravascular injection, patients-assessed pain relief for one month and complications.Results:The Tfand Ttwere shorter in the OS than in the AP group (24.4 ± 24.0 s vs 47. 8 ± 53.2seconds; 93.3 ± 35.0 seconds vs 160.0 ± 98.7 seconds, P < .001, both). Incidence of intravascular injection (AP, 8 [22.8%]; OS, 4 [11.4%], P = .205), pain score, and complication rates were not statistically different between the two groups. In logistic regression analysis, the body mass index (BMI) was a risk factor for longer Tt(odds ratio [OR] = 1.27, 95% CI: 1.02-1.58, P = .030).Conclusion:The passage time of the needle into S1 foramen was shorter in OS approach and the OS approach reduced the procedure time compared with the AP approach during S1 TFESI. The practitioners should note that procedure time can be prolonged in obese patients. © 2020 Lippincott Williams and Wilkins. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Lippincott Williams and Wilkins | - |
dc.title | Comparison between anteroposterior and oblique Scotty dog approach during S1 transforaminal epidural steroid injection: A randomized controlled trial | - |
dc.type | Article | - |
dc.identifier.doi | 10.1097/MD.0000000000022895 | - |
dc.identifier.bibliographicCitation | Medicine (United States), v.99, no.43 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85095397312 | - |
dc.citation.number | 43 | - |
dc.citation.title | Medicine (United States) | - |
dc.citation.volume | 99 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | anteroposterior | - |
dc.subject.keywordAuthor | approach | - |
dc.subject.keywordAuthor | oblique | - |
dc.subject.keywordAuthor | procedure time | - |
dc.subject.keywordAuthor | S1 transforaminal epidural steroid injection | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.